MIM
RBOT

MetLife Investment Management’s Vicarious Surgical RBOT Stock Holding History

MetLife Investment Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,109
Closed -$60.9K – 2962
2023
Q2 		$60.9K Hold
1,109
– – ﹤0.01% 2879
2023
Q1 		$75.5K Buy
1,109
+590
+114% +$45.9K ﹤0.01% 2653
2022
Q4 		$31.5K Sell
519
-588
-53% -$54.7K ﹤0.01% 2794
2022
Q3 		$111K Hold
1,107
– – ﹤0.01% 2631
2022
Q2 		$97.7K Buy
+1,107
New +$135K ﹤0.01% 2718

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.6B AUM 17.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

MetLife Investment Management's RBOT Position: Q3 2023 in Review

MetLife Investment Management sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 1,109 shares — an estimated $60.9K sold.

MetLife Investment Management first reported a position in RBOT in Q2 2022 and held it in 5 quarters. The position peaked at $111K in Q3 2022. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • MetLife Investment Management reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 1,109 Vicarious Surgical shares in Q3 2023, an estimated $60.9K.
  • MetLife Investment Management first reported a position in Vicarious Surgical in Q2 2022 and held it in 5 quarters.
  • MetLife Investment Management's Vicarious Surgical position peaked at $111K in Q3 2022.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.